Abstracts tagged "gout and radiology"

Abstract Number: 2204 • 2018 ACR/ARHP Annual Meeting
Clinical Utility of a Multi-Energy Spectral CT in Crystal Arthritis
Lisa K. Stamp¹, Nigel Anderson², Fabio Becce³, Maya Rajeswari², Matthew Polson⁴, Olivier Guyen³, Anais Viry³, Chloe Choi², Tracy Kirkbride⁵ and Aamir Raja², ¹University of Otago, Christchurch, New Zealand, ²University of Otago, Christchurch, Christchurch, New Zealand, ³Lausanne University Hospital, Lausanne, Switzerland, ⁴University of Canterbury, Christchurch, New Zealand, ⁵Ara Institute of Canterbury, Christchurch, New Zealand
Background/Purpose: The gold standard for the diagnosis of crystal-related arthritis requires aspiration and visualization of crystals from synovial fluid or tophus material. However, crystal identification…
Abstract Number: 2148 • 2014 ACR/ARHP Annual Meeting
Dual Energy CT Scanning: Variable Sensitivity for Gout in Non-Tophaceous and Tophaceous Disease and in Individual Erosions
Tracie Kurano¹, Uma Thakur², Gaurav Thawait³, Elliot Fishman⁴, Mara McAdams-DeMarco⁵, Janet W. Maynard⁶, Matthew Fuld⁷, John A. Carrino⁸ and Alan N. Baer⁹, ¹Medicine-Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ²Musculoskeletal Radiology Section, Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, ³Musculoskeletal Radiology Section, Johns Hopkins University School of Medicine, Baltimore, MD, ⁴Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, ⁵Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, ⁶Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ⁷Research Collaborations - Computed Tomography R&D, Siemens Medical Solutions USA, Inc., Baltimore, MD, ⁸Radiology, Hospital for Special Surgery, New York, NY, ⁹Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD
Background/Purpose: Dual energy computed tomography (DECT) is emerging as a diagnostic tool for gout, but its sensitivity has not been established. We assessed the sensitivity…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].